E-LIB Suche - Ergebnisse für: Kakuta, Hirotoshi

1

Bixalomer, a novel phosphate binder with a small swelling i..:

Taniguchi, Keiichi ; Kakuta, Hirotoshi
European Journal of Pharmacology. 766 (2015) - p. 129-134 , 2015

2

Brain penetration of telmisartan, a unique centrally acting..:

Noda, Akihiro ; Fushiki, Hiroshi ; Murakami, Yoshihiro...
Nuclear Medicine and Biology. 39 (2012) 8 - p. 1232-1235 , 2012

Link: https://doi.org/10.1016/..

3

Unique "delta lock" structure of telmisartan is involved in..:

Ohno, Kazuki ; Amano, Yasushi ; Kakuta, Hirotoshi...
Biochemical and Biophysical Research Communications. 404 (2011) 1 - p. 434-437 , 2011

Link: https://doi.org/10.1016/..

4

An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisa..:

Applied Pharmacology II Pharmacology Research Laboratory, Drug Discovery Research, Astellas Pharma Inc., Japan ; Kakuta, Hirotoshi ; Takasu, Toshiyuki..
International Journal of Biomedical Science. 2 (2006) 4 - p. 333-336 , 2006

Link: https://doi.org/10.59566..

5

Effects of Atorvastatin on Glucose Metabolism and Insulin R..:

Suzuki, Masatsune ; Kakuta, Hirotoshi ; Takahashi, Akimitsu...
Journal of Atherosclerosis and Thrombosis. 12 (2005) 2 - p. 77-84 , 2005

Link: https://doi.org/10.5551/..

6

Synthesis and biological evaluation of novel propylamine de..:

Ishihara, Tsukasa ; Kakuta, Hirotoshi ; Moritani, Hiroshi..
Bioorganic & Medicinal Chemistry. 12 (2004) 22 - p. 5899-5908 , 2004

Link: https://doi.org/10.1016/..

7

Synthesis and Biological Evaluation of Quinuclidine Derivat..:

Ishihara, Tsukasa ; Kakuta, Hirotoshi ; Moritani, Hiroshi..
Chemical and Pharmaceutical Bulletin. 52 (2004) 10 - p. 1204-1209 , 2004

Link: https://doi.org/10.1248/..

8

Experimental model of postprandial hypertriglyceridemia in ..:

Funatsu, Toshiyuki ; Kakuta, Hirotoshi ; Takasu, Toshiyuki...
Metabolism. 52 (2003) 5 - p. 609-615 , 2003

Link: https://doi.org/10.1053/..

9

Syntheses and biological evaluation of novel quinuclidine d..:

Ishihara, Tsukasa ; Kakuta, Hirotoshi ; Moritani, Hiroshi...
Bioorganic & Medicinal Chemistry. 11 (2003) 11 - p. 2403-2414 , 2003

Link: https://doi.org/10.1016/..

10

YM‐53601, a novel squalene synthase inhibitor, suppresses l..:

Ugawa, Tohru ; Kakuta, Hirotoshi ; Moritani, Hiroshi..
British Journal of Pharmacology. 139 (2003) 1 - p. 140-146 , 2003

Link: https://doi.org/10.1038/..

11

Syntheses of 3-Ethylidenequinuclidine derivatives as squale..:

Ishihara, Tsukasa ; Kakuta, Hirotoshi ; Moritani, Hiroshi...
Bioorganic & Medicinal Chemistry. 11 (2003) 17 - p. 3735-3745 , 2003

Link: https://doi.org/10.1016/..

12

Effect of YM‐53601, a novel squalene synthase inhibitor, on..:

Ugawa, Tohru ; Kakuta, Hirotoshi ; Moritani, Hiroshi.
British Journal of Pharmacology. 137 (2002) 4 - p. 561-567 , 2002

Link: https://doi.org/10.1038/..

13

Experimental model of escape phenomenon in hamsters and the..:

Ugawa, Tohru ; Kakuta, Hirotoshi ; Moritani, Hiroshi.
British Journal of Pharmacology. 135 (2002) 6 - p. 1572-1578 , 2002

Link: https://doi.org/10.1038/..

14

Atorvastatin increases hepatic fatty acid beta-oxidation in..:

Funatsu, Toshiyuki ; Kakuta, Hirotoshi ; Takasu, Toshiyuki.
European Journal of Pharmacology. 455 (2002) 2-3 - p. 161-167 , 2002

Link: https://doi.org/10.1016/..

15

YM‐53601, a novel squalene synthase inhibitor, reduces plas..:

Ugawa, Tohru ; Kakuta, Hirotoshi ; Moritani, Hirosh...
British Journal of Pharmacology. 131 (2000) 1 - p. 63-70 , 2000

Link: https://doi.org/10.1038/..